The Power of Probiotics to Combat Urinary Tract Infections: A Comprehensive Review
Article Sidebar
XML-PubMed downloads: 19
XML-DOAJ downloads: 19
PDF downloads: 92
XML-Crossref downloads: 6
Crossref Citations: 0
Main Article Content
Abstract
Urinary tract infections (UTIs) are among the most common bacterial infections and can cause significant morbidity, particularly in women. Recurrent UTIs are a significant clinical problem, and current prophylactic measures, such as antibiotics, are associated with side effects and the risk of antimicrobial resistance. Probiotics, defined as live microorganisms that confer health benefits to the host, have emerged as a potential alternative to traditional treatments for recurrent UTIs.
Probiotics can act by modulating the host's immune system, competitively excluding uropathogens, and producing antibacterial substances, such as bacteriocins. Clinical evidence supports the use of probiotics as a safe and effective intervention for the prevention and treatment of recurrent UTIs. However, selecting appropriate probiotic strains for UTIs can be challenging, and the safety and efficacy of probiotics depend on the strain, dosage, and timing of administration.
The safety profile of probiotics is generally excellent, and side effects are usually mild and self-limiting. However, certain populations, such as immunocompromised and critically ill patients, may be at increased risk of adverse events, and caution should be exercised when considering probiotic use in these populations. Strategies for ensuring probiotic safety and efficacy include adherence to good manufacturing practices, rigorous testing for the presence of contaminants, and standardization of dosing and administration protocols.
Despite the potential of probiotics for the prevention and treatment of recurrent UTIs, several challenges and limitations remain. These include limited access to high-quality probiotic products, challenges in selecting appropriate strains, and lack of consensus regarding optimal dosing and duration of probiotic use. Future research should focus on identifying optimal probiotic strains and regimens for the prevention and treatment of UTIs, understanding the role of gut microbiota in urogenital health, and developing new probiotic technologies and delivery methods.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Salahshoori Niaei F, Farah Taj Navab A. Effects of Valeriana officinalis and ciprofloxacin on kidney histopathology in rats pyelonephritis by pseudomonas aeruginosa. Rev Environ Sci Biotechnol. 2022; 1(1): 23-27. Available at: https://rbes.rovedar.com/article_160898.html
Foxman B. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014; 28(1), 1–13. DOI: https://doi.org/10.1016/j.idc.2013.09.003
Valiquette L. Urinary tract infections in women. Can J Urol. 2001; 8(Supple 1): 6-12. Available at: https://pubmed.ncbi.nlm.nih.gov/11442991/
Flores-Mireles AL, Walker JN, Caparon M, and Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol, 2015; 13(5): 269-284. DOI: https://doi.org/10.1038/nrmicro3432
Mego M, Holec V, Drgona L, Hainova K, Ciernikova S, and Zajac V. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med. 2013; 21(6): 712-723. DOI: https://doi.org/10.1016/j.ctim.2013.08.018
Afolayan AO, Adetoye A, and Ayeni FA. Beneficial microbes: Roles in the era of antimicrobial resistance. In Kumar Y, editor. Antimicrobial resistance-A global threat. 2018. Available at: https://www.intechopen.com/chapters/63124
Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, and Starkey MR. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol. 2021; 14(4): 779-792. DOI: https://doi.org/10.1038/s41385-020-00372-5
Martín R, and Langella P. Emerging health concepts in the probiotics field: Streamlining the definitions. Front microb. 2019; 10: 1047. DOI: https://doi.org/10.3389%2Ffmicb.2019.01047
Sánchez B, Delgado S, Blanco‐Míguez A, Lourenço A, Gueimonde M, and Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017; 61(1): 1600240. DOI: https://doi.org/10.1002/mnfr.201600240
Ng QX, Peters C, Venkatanarayanan N, Goh YY, Ho CY, and Yeo WS. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses. 2018; 114: 49-54. DOI: https://doi.org/10.1016/j.mehy.2018.03.001
Heidari F, Abbaszadeh S, and Mirak SE. Evaluation effect of combination probiotics and antibiotics in the prevention of recurrent urinary tract infection (UTI) in women. Biomed Pharmacol J. 2017; 10(2): 691-698. DOI: https://doi.org/10.13005/bpj/1157
Mantegazza C, Molinari P, D’Auria E, Sonnino M, Morelli L, and Zuccotti GV. Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacol Res. 2018; 128: 63-72. DOI: https://doi.org/10.1016/j.phrs.2017.08.001
Kim WB, Cho KH, Lee SW, Yang HJ, Yun JH, Lee KW, et al. Recent antimicrobial susceptibilities for uropathogenic Escherichia coli in patients with community acquired urinary tract infections: A multicenter study. Urogenit Tract Infect. 2017; 12(1): 28-34. DOI: https://doi.org/10.14777/uti.2017.12.1.28
Clegg S, and Murphy CN. Epidemiology and virulence of Klebsiella pneumoniae. Microbiol Spectr. 2017; 4(1): 435-457. DOI: https://doi.org/10.1128/microbiolspec.uti-0005-2012
Fusco A, Coretti L, Savio V, Buommino E, Lembo F, and Donnarumma G. Biofilm formation and immunomodulatory activity of Proteus mirabilis clinically isolated strains. Int J Mol Sci. 2017; 18(2): 414. DOI: https://doi.org/10.3390/ijms18020414
Silva A, Costa E, Freitas A, and Almeida A. Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections. Antibiotics. 2022; 11(6): 768. DOI: https://doi.org/10.3390/antibiotics11060768
Ciofu O, and Tolker-Nielsen T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. aeruginosa can escape antibiotics. Front microbiol. 2019; 10: 913. DOI: https://doi.org/10.3389/fmicb.2019.00913
Mahto KU, Vandana, Priyadarshanee M, Samantaray DP, and Das S. Bacterial biofilm and extracellular polymeric substances in the treatment of environmental pollutants: Beyond the protective
role in survivability. J Clean Prod. 2022; 379: 134759. DOI: https://doi.org/10.1016/j.jclepro.2022.134759
Serwecińska L. Antimicrobials and antibiotic-resistant bacteria: A risk to the environment and to public health. Water. 2020; 12(12): 3313. DOI: https://doi.org/10.3390/w12123313
Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, and Cohen H. Antibiotics as major disruptors of gut microbiota.
Front Cell Infect Microbiol. 2020; 10: 572912. DOI: https://doi.org/10.3389/fcimb.2020.572912
Hashempour-Baltork F, Sheikh M, Eskandarzadeh S, Tarlak F, Tripathi AD, Khosravi-Darani K, et al. The Effect of probiotics on various diseases and their therapeutic role: An update review. J Pure Appl Microbiol. 2021; 15(3): 1042-1059. DOI: https://doi.org/10.22207/JPAM.15.3.17
Ghane M, Babaeekhou L, and Ketabi SS. Antibiofilm activity of kefir probiotic lactobacilli against uropathogenic Escherichia coli (UPEC). Avicenna J Med Biotechnol. 2020; 12(4): 221-229. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502162/
Gümüş D, Yüksek FK, Bilgin M, Camadan FD, and Küçüker MA. In Vitro effects of various probiotic products on growth and biofilm formation of clinical UPEC strains. Acta Biol Marisiensis. 2020; 3(1): 5-14. DOI: https://doi.org/10.2478/abmj-2020-0001
Dargahi N, Matsoukas J, and Apostolopoulos V. Streptococcus thermophilus ST285 alters pro-inflammatory to anti-inflammatory cytokine secretion against multiple sclerosis peptide in mice. Brain sci. 2020; 10(2): 126. DOI: https://doi.org/10.3390/brainsci10020126
Barrientos-Durán A, Fuentes-López A, de Salazar A, Plaza-Díaz J, and García F. Reviewing the composition of vaginal microbiota: Inclusion of nutrition and probiotic factors in the maintenance of eubiosis. Nutrients. 2020; 12(2): 419. DOI: https://doi.org/10.3390/nu12020419
Koradia P, Kapadia S, Trivedi Y, Chanchu G, and Harper A. Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: A controlled pilot study. Expert Rev Anti Infect Ther. 2019; 17(9): 733-740. DOI: https://doi.org/10.1080/14787210.2019.1664287
Beyitler I, and Kavukcu S. Probiotics for prophylaxis and treatment of urinary tract infections in children. Iran J Pediatr. 2017; 27(2): e7695. DOI: https://doi.org/10.5812/ijp.7695
Akgül T, and Karakan T. The role of probiotics in women with recurrent urinary tract infections. Turk J Urol. 2018; 44(5): 377-383. DOI: https://doi.org/10.5152%2Ftud.2018.48742
Saha UB, and Saroj SD. Lactic acid bacteria: Prominent player in the fight against human pathogens. Expert Rev Anti Infect Ther. 2022; 20(11): 1435-1453. DOI: https://doi.org/10.1080/14787210.2022.2128765
Babazadeh D, Vahdatpour T, Nikpiran H, Jafargholipour MA, and Vahdatpour S. Effects of probiotic, prebiotic and synbiotic intake on blood enzymes and performance of Japanese quails (Coturnix japonica). Indian J Anim Sci. 2011; 81(8): 870-874.
Mirzaei A, Razavi SA, Babazadeh D, Laven R, and Saeed M. Roles of Probiotics in Farm Animals: A Review. FAHN. 2022; 1(1): 17-25. Available at: https://fahn.rovedar.com/article_160928_e7a5fc9842a2220112f64d aeb52316ed.pdf
Sikorska H, and Smoragiewicz W. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2013; 42(6): 475-481. DOI: https://doi.org/10.1016/j.ijantimicag.2013.08.003
Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, et al. The administration of Escherichia coli Nissle 1917 ameliorates development of DSS-induced colitis in mice. Front pharmacol. 2018; 9: 468. DOI: https://doi.org/10.3389/fphar.2018.00468
Crittenden RG, Martinez NR, and Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol. 2003; 80(3): 217-222. DOI: 1016/s0168-1605(02)00170-8
Vahdatpour T, and Babazadeh D. The effects of Kefir rich in probiotic administration on serum enzymes and performance in male Japanese quails. J Anim Plant Sci. 2016; 26(1): 34-39. Available at: https://www.thejaps.org.pk/docs/v-26-01/05.pdf
Mendonça FH, Santos SS, Faria ID, Gonçalves e Silva CR, Jorge AO, and Leão MV. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J. 2012; 23: 534-538. DOI: https://doi.org/10.1590/s0103-64402012000500011
Abraham SN, and Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015; 15(10): 655-663. DOI: https://doi.org/10.1038/nri3887
Gupta V, Nag D, and Garg P. Recurrent urinary tract infections in women: How promising is the use of probiotics?. Indian J Med Microbiol. 2017; 35(3): 347-354. DOI: https://doi.org/10.4103/ijmm.ijmm_16_292
Petrova MI, Reid G, and Ter Haar JA. Lacticaseibacillus rhamnosus GR-1, aka Lactobacillus rhamnosus GR-1: Past and future perspectives. Trends Microbiol. 2021; 29(8): 747-761. DOI: https://doi.org/10.1016/j.tim.2021.03.010
Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012; 172: 704-712. DOI: https://doi.org/10.1001/archinternmed.2012.777
16. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo controlled Phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for the prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52(10): 1212–1217. DOI: https://doi.org/10.1093/cid/cir183
Gao J, Zhao L, Cheng Y, Lei W, Wang Y, Liu X, et al. Probiotics for the treatment of depression and its comorbidities: A systemic review. Front Cell Infect Microbio. 2023; 13: 1167116. DOI: https://doi.org/10.3389/fcimb.2023.1167116
Khalesi S, Johnson DW, Campbell K, Williams S, Fenning A, Saluja S, et al. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: A systematic review and meta-analysis. Eur J Nutr. 2018; 57(6): 2037-2053. DOI: https://doi.org/10.1007/s00394-017-1568-y
Czaja CA, Stapleton AE, Yarova-Yarovaya Y, and Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol. 2007; 2007: 35387. DOI: https://doi.org/10.1155/2007/35387
Josephs-Spaulding J, Krogh TJ, Rettig HC, Lyng M, Chkonia M, Waschina S, et al. Recurrent urinary tract infections: Unraveling the complicated environment of uncomplicated rUTIs. Front Cell Infect Microbiol. 2021; 11: 562525. DOI: https://doi.org/10.3389/fcimb.2021.562525
Boeri L, Capogrosso P, Ventimiglia E, Scano R, Graziottin A, Dehò F, et al. Six out of ten women with recurrent urinary tract infections complain of distressful sexual dysfunction–A case-control study. Sci rep. 2017; 7: 44380. DOI: https://doi.org/10.1038%2Fsrep44380
Chen YC, Lee WC, and Chuang YC. Emerging non-antibiotic options targeting uropathogenic mechanisms for recurrent uncomplicated urinary tract infection. Int J Mol Sci. 2023; 24(8): 7055. DOI: https://doi.org/10.3390/ijms24087055
Chee WJ, Chew SY, and Than LT. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb
Cell Factories. 2020; 19: 203. Available at: https://link.springer.com/article/10.1186/s12934-020-01464-4
Watson RA. Enlisting probiotics to combat recurrent urinary tract infections in women—A military strategy for meeting the challenge. Antibiotics. 2023; 12(1): 167. DOI: https://doi.org/10.3390/antibiotics12010167
Graham K, Stack H, and Rea R. Safety, beneficial and technological properties of enterococci for use in functional food applications–a review. Crit Rev Food Sci Nutr. 2020; 60(22): 3836-3861. DOI: https://doi.org/10.1080/10408398.2019.1709800
Chowdhury AH, Adiamah A, Kushairi A, Varadhan KK, Krznaric Z, Kulkarni AD, et al. Perioperative probiotics or synbiotics in adults undergoing elective abdominal surgery: A systematic review and meta-analysis of randomized controlled trials. Ann surg. 2020; 271(6): 1036-1047. Available at: https://journals.lww.com/ annalsofsurgery/Fulltext/2020/06000/Perioperative_Probiotics_or_Synbiotics_in_Adults.12.aspx?context=LatestArticles
Blaabjerg S, Artzi DM, and Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients—a systematic
review and meta-analysis. Antibiotics. 2017; 6(4): 21. DOI: https://doi.org/10.3390/antibiotics6040021
Kothari D, Patel S, and Kim SK. Probiotic supplements might not be universally-effective and safe: A review. Biomed Pharmacother. 2019; 111: 537-547. DOI: https://doi.org/10.1016/j.biopha.2018.12.104
Reyna-Figueroa J, Barrón-Calvillo E, García-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Martínez A, et al. Probiotic supplementation decreases chemotherapy-induced gastrointestinal side effects in patients with acute leukemia. J Pediatr Hematol Oncol. 2019; 41(6): 468-472. DOI: https://doi.org/10.1097/MPH.0000000000001497
Wilkins T, and Sequoia J. Probiotics for gastrointestinal conditions: A summary of the evidence. Am Fam Physician. 2017; 96(3): 170-178. Available at: https://europepmc.org/article/med/28762696
Schreck Bird A, Gregory PJ, Jalloh MA, Risoldi Cochrane Z, and Hein DJ. Probiotics for the treatment of infantile colic: A systematic review. J Pharm Pract. 2017; 30(3): 366-374. DOI: https://doi.org/10.1177/0897190016634516
Di Gioia D, and Biavati B. Probiotics and prebiotics in animal health and food safety: Conclusive remarks and future perspectives. In Di Gioia D, Biavati B, editors. Probiotics and prebiotics in animal health and food safety. Springer, Cham; 2018. p. 269-273. Avialable at: https://link.springer.com/chapter/10.1007/978-3-319-71950-4_11#citeas
Roobab U, Batool Z, Manzoor MF, Shabbir MA, Khan MR, and Aadil RM. Sources, formulations, advanced delivery and health benefits
of probiotics. Curr Opin Food. 2020; 32: 17-28. DOI: https://doi.org/10.1016/j.cofs.2020.01.003
Merrick B, Allen L, Zain NM, Forbes B, Shawcross DL, and Goldenberg SD. Regulation, risk and safety of faecal microbiota transplant. Infect Prev Pract. 2020; 2(3): 100069. DOI: https://doi.org/10.1016%2Fj.infpip.2020.100069
Kong Y, Liu Z, Xiao Q, Wu F, Hu L, Deng X, and Chen T. Protective effects of engineered lactobacillus crispatus on intrauterine adhesions in mice via delivering CXCL12. Front Immunol. 2022: 13: 905876. DOI: https://doi.org/10.3389/fimmu.2022.905876
Jantarathin S, Borompichaichartkul C, and Sanguandeekul R. Microencapsulation of probiotic and prebiotic in alginate-chitosan capsules and its effect on viability under heat process in shrimp feeding. Mater Today: Proc. 2017; 4(5 part 2): 6166-6172. DOI: https://doi.org/10.1016/j.matpr.2017.06.111
Kustrimovic N, Bombelli R, Baci D, and Mortara L. Microbiome and prostate cancer: A novel target for prevention and treatment. Int J Mol Sci. 2023; 24(2): 1511. DOI: https://doi.org/10.3390/ijms24021511